Zhongyin lawyers advised Guangdong New South Artemisia Annua Medicine Co., Ltd. ’s NEEQ listing
the last working day of 2016, when the NEEQ listed companies in the total
number of 10163, receiving the consent letter of “NEEQ Consent
Letter: Number 9934”，Guangdong
New South Artemisia Annua Medicine Co., Ltd. (code:
870644) was successfully listed on NEEQ with Zhongyin senior partner, Gao Wei lawyers
team ’s professional services. And this very day is also the 86th birthday of
Mrs.Tu Youyou, the Nobel prize owner of our country.
The main business of New South is
artemisinin antimalarial medicine, traditional Chinese medicine general
medicine and all kinds of extract research and development, production and
sales. The main products are artemisinin piperazine tablets, Chinese medicine
generic drugs and various types of extract. ARTEQUICK is the artemisinin drug
with independent intellectual property rights of artemisinin compound drugs,
which is also one of the core products of Artemisia annua medicine. Many years
ago, the president of Guangdong New South Group Co., Ltd (the controlling
shareholder of Qinghao Pharmaceutical), Mr. Zhu Layi put forward the research
and development and production of artemisinin compound research project.
Artemisinin known for the Nobel Prize in the world, but the discovery of Tu
Youyou applied to clinical and research and development of China with full
intellectual property rights of artemisinin compound drugs, mainly with the
pharmaceutical research and Artemisia Annua development team.
Occasional contains the
inevitable. As Ms. Tu Youyou’s 86th birthday gift, the birth of China's capital
market, the first "Artemisia annua mission, global health” responsibility
of the NEEQ business. If the Nobel Prize ignited the common cause of China's
Artemisia annua enthusiasm, then the capital market was injected into its
inexhaustible endogenous motivation.